Scientific
publications

Working closely with our partnered centres and universities, our researchers contribute to the progress of Life Sciences knowledge.

Biomedicine & Pharmacotherapy March 2020

Inhibition of osteoclast activity by complement regulation with DF3016A, a novel small-molecular-weight C5aR inhibitor

R D'Angelo et al.

Nature February 2020

Topical recombinant human Nerve growth factor (rh-NGF) is neuroprotective to retinal ganglion cells by targeting secondary degeneration

Guo, L., Davis, B.M., Ravindran, N. et al.

Aging January 2020

Autocrine CXCL8-dependent invasiveness triggers modulation of actin cytoskeletal network and cell dynamics

A Antonosante et al.

Ophthalmology January 2020

Topical Recombinant Human Nerve Growth Factor (Cenegermin) for Neurotrophic Keratopathy: A Multicenter Randomized Vehicle-Controlled Pivotal Trial

SC Pflugfelder et al.

The British journal of ophthalmology January 2020

Effect of Recombinant Human Nerve Growth Factor Eye Drops in Patients With Dry Eye: A Phase IIa, Open Label, Multiple-Dose Study

M Sacchetti et al.

J Int Soc Sports Nutr. January 2020

Effects of a commercially available branched-chain amino acid-alaninecarbohydrate-based sports supplement on perceived exertion and performance in high intensity endurance cycling tests

M. Gervasi, D. Sisti, S.o Amatori, S. Donati Zeppa, G. Annibalini, G. Piccoli, L. Vallorani, P. Benelli, M. B. L. Rocchi, E. Barbieri, A. R. Calavalle, D. Agostini, C. Fimognari, V. Stocchi, P.Sestili

Multidiscip Respir Med December 2019

Focus on the cetirizine use in clinical practice: a reappraisal 30 years later

A. G. Corsico, S. Leonardi, A.Licari, G. Marseglia, M. Miraglia del Giudice, D. G. Peroni, C. Salpietro, G. Ciprandi

Molecules October 2019

Catalyst-Free Synthesis of Polysubstituted 5-Acylamino-1,3-Thiazoles via Hantzsch Cyclization of α-Chloroglycinates

M Tomassetti et al.

Nature August 2019

DF2726A, a new IL-8 signalling inhibitor, is able to counteract chemotherapy-induced neuropathic pain

L Brandolini et al.

Eur Rev Med Pharmacol Sci August 2019

A prospective study of the effects of carbocysteine lysine salt on frequency of exacerbations in COPD patients treated with or without inhaled steroids

G. PAONE, L. LANATA, F. SAIBENG. PAONE, L. LANATA, F. SAIBENE, S. TOTI, P. PALERMO, C. GRAZIANI, M.C. FLORE, M. RAMACCIA, G. PUGLISIE, S. TOTI, P. PALERMO, C. GRAZIANI, M.C. FLORE, M. RAMACCIA, G. PUGLISI

Publications per author: 57
Citations: 1699
H-index (2015-2016): 39.5
H-index (2017-2018): 42.4
H-index (2019-2020): 51.5

Number of documents to citations ratio

Source: Elsevier Scopus

Weighted number of publications per thematic area

Source: Elsevier Scopus

Dompé Farmaceutici S.p.A. Single shareholder company / Share capital € 50.000.000,00
REA MI 289519 - A registered company in Milan, Italy / Tax code and VAT number IT00791570153